Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
Clinical trial NCT03490669 · COMPLETED
Trial details
- NCT number
- NCT03490669
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2019-09-23
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.